Literature DB >> 12673649

Behavioral assessment of children with Down syndrome using the Reiss psychopathology scale.

Debbie Clark1, Golder N Wilson.   

Abstract

The behavior of 60 children with Down syndrome (cDS), aged 4 to 21 years, was assessed by parent and teacher report using the Reiss psychopathology rating scale for dual diagnosis (mental disability plus mental illness). Standard forms contained 12 categories of abnormal behavior (e.g., Psychosis), each with five descriptive items (e.g., bizarre ideas) that could be scored as no problem, problem, and major problem (0, 1, or 2 points). Total scores for individual cDS (mean of two raters) ranged from 3 to 43 out of a potential 120 points, with a mean of 14.8 points and a standard deviation of 9.5. There were no significant differences by sex, age, or ethnicity. The highest aggregate scores among the 60 cDS were in the psychometric categories of Attention-Deficit (156 points), Anger/Self Control (154.5), and Psychosis (109) and for component items such as communication problems (55 points) under the Psychosis category; distracted (48.5) or disobedient (42.5) under the Attention-Deficit category; and temper tantrums (36.5), impulsive (32), or impatient (31.5) under the Anger/Self-Control category. Agreement between parent and teacher raters was over 75% for 38 of the 60 items and above 60% for an additional 15. Selection of cDS with scores over 10 points yielded 24 families who chose parental guidance and 14 who chose professional referral. The structure of the Reiss instrument was useful for cDS, distinguishing behaviors potentially related to medical problems from true psychopathology. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12673649     DOI: 10.1002/ajmg.a.20007

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Attentional function and basal forebrain cholinergic neuron morphology during aging in the Ts65Dn mouse model of Down syndrome.

Authors:  Brian E Powers; Ramon Velazquez; Christy M Kelley; Jessica A Ash; Myla S Strawderman; Melissa J Alldred; Stephen D Ginsberg; Elliott J Mufson; Barbara J Strupp
Journal:  Brain Struct Funct       Date:  2015-12-30       Impact factor: 3.270

2.  Maternal Choline Supplementation: A Potential Prenatal Treatment for Down Syndrome and Alzheimer's Disease.

Authors:  Barbara J Strupp; Brian E Powers; Ramon Velazquez; Jessica A Ash; Christy M Kelley; Melissa J Alldred; Myla Strawderman; Marie A Caudill; Elliott J Mufson; Stephen D Ginsberg
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

3.  Fecal corticosterone levels in RCAN1 mutant mice.

Authors:  Tammy Rakowski-Anderson; Helen Wong; Beverly Rothermel; Peter Cain; Carmencita Lavilla; Jennifer K Pullium; Charles Hoeffer
Journal:  Comp Med       Date:  2012-04       Impact factor: 0.982

4.  Resting-State Functional Connectivity in Individuals with Down Syndrome and Williams Syndrome Compared with Typically Developing Controls.

Authors:  Jennifer N Vega; Timothy J Hohman; Jennifer R Pryweller; Elisabeth M Dykens; Tricia A Thornton-Wells
Journal:  Brain Connect       Date:  2015-04-28

5.  Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome.

Authors:  Tatjana Begenisic; Maria Spolidoro; Chiara Braschi; Laura Baroncelli; Marco Milanese; Gianluca Pietra; Maria E Fabbri; Giambattista Bonanno; Giovanni Cioni; Lamberto Maffei; Alessandro Sale
Journal:  Front Cell Neurosci       Date:  2011-12-23       Impact factor: 5.505

6.  Characterization of PTZ-induced seizure susceptibility in a down syndrome mouse model that overexpresses CSTB.

Authors:  Véronique Brault; Benoît Martin; Nathalie Costet; Jean-Charles Bizot; Yann Hérault
Journal:  PLoS One       Date:  2011-11-30       Impact factor: 3.240

7.  Disruptive behavior in Down syndrome children: a cross-sectional comparative study.

Authors:  Sohier Yahia; Mohamed El-Hadidy; Abdel-Hady El-Gilany; Dina Amdel-Hady; Yahya Wahba; Mohammad Al-Haggar
Journal:  Ann Saudi Med       Date:  2014 Nov-Dec       Impact factor: 1.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.